These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37969593)

  • 1. Structure-guided optimisation of
    Corner TP; Teo RZR; Wu Y; Salah E; Nakashima Y; Fiorini G; Tumber A; Brasnett A; Holt-Martyn JP; Figg WD; Zhang X; Brewitz L; Schofield CJ
    Chem Sci; 2023 Nov; 14(43):12098-12120. PubMed ID: 37969593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and Enarodustat.
    Corner TP; Salah E; Tumber A; Kaur S; Nakashima Y; Allen MD; Schnaubelt LI; Fiorini G; Brewitz L; Schofield CJ
    ChemMedChem; 2024 Dec; 19(24):e202400504. PubMed ID: 39291299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
    Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
    J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
    Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
    J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Small-Molecule Inhibitor of Factor Inhibiting HIF Binding to a Tyrosine-Flip Pocket for the Treatment of Obesity.
    Wu Y; Chen Y; Corner TP; Nakashima Y; Salah E; Li Z; Zhang L; Yang L; Tumber A; Sun Z; Wen Y; Zhong A; Yang F; Li X; Zhang Z; Schofield CJ; Zhang X
    Angew Chem Int Ed Engl; 2024 Oct; 63(40):e202410438. PubMed ID: 38923188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases.
    Nakashima Y; Brewitz L; Tumber A; Salah E; Schofield CJ
    Nat Commun; 2021 Nov; 12(1):6478. PubMed ID: 34759269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH).
    Flagg SC; Martin CB; Taabazuing CY; Holmes BE; Knapp MJ
    J Inorg Biochem; 2012 Aug; 113():25-30. PubMed ID: 22687491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
    Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
    J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
    Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
    J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5.
    Tumber A; Salah E; Brewitz L; Corner TP; Schofield CJ
    RSC Chem Biol; 2023 Jun; 4(6):399-413. PubMed ID: 37292060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
    Hewitson KS; Liénard BM; McDonough MA; Clifton IJ; Butler D; Soares AS; Oldham NJ; McNeill LA; Schofield CJ
    J Biol Chem; 2007 Feb; 282(5):3293-301. PubMed ID: 17135241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry of the hypoxia-inducible factor hydroxylases.
    Fiorini G; Schofield CJ
    Curr Opin Chem Biol; 2024 Apr; 79():102428. PubMed ID: 38330792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
    Hewitson KS; McNeill LA; Riordan MV; Tian YM; Bullock AN; Welford RW; Elkins JM; Oldham NJ; Bhattacharya S; Gleadle JM; Ratcliffe PJ; Pugh CW; Schofield CJ
    J Biol Chem; 2002 Jul; 277(29):26351-5. PubMed ID: 12042299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
    Strowitzki MJ; Cummins EP; Taylor CT
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.
    Wu Y; Li Z; McDonough MA; Schofield CJ; Zhang X
    J Med Chem; 2021 Jun; 64(11):7189-7209. PubMed ID: 34029087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.
    Lancaster DE; McNeill LA; McDonough MA; Aplin RT; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
    Biochem J; 2004 Nov; 383(Pt. 3):429-37. PubMed ID: 15239670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
    Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
    Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor.
    Linke S; Hampton-Smith RJ; Peet DJ
    Methods Enzymol; 2007; 435():61-85. PubMed ID: 17998049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.
    Yeh TL; Leissing TM; Abboud MI; Thinnes CC; Atasoylu O; Holt-Martyn JP; Zhang D; Tumber A; Lippl K; Lohans CT; Leung IKH; Morcrette H; Clifton IJ; Claridge TDW; Kawamura A; Flashman E; Lu X; Ratcliffe PJ; Chowdhury R; Pugh CW; Schofield CJ
    Chem Sci; 2017 Nov; 8(11):7651-7668. PubMed ID: 29435217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.